Complete Health Economics Outcomes Research Solutions (dba, CHEORS) acquired by PharmAlliance, a portfolio company of Waud Capital

Apr. 2024

Client: CHEORS is a leading, multinational HEOR and market access provider delivering high-impact, data-driven insights to the biotech and pharmaceutical industry

Role: Edgemont Partners acted as exclusive financial advisor to CHEORS in its sale to PharmAlliance, a portfolio company of Waud Capital

Location: North Wales, PA

Sector: Pharmaceutical Services

Lead Banker: Andrew Karlin